1.1 Current evidence on percutaneous coblation of the intervertebral disc for low back pain and sciatica raises no major safety concerns. The evidence on efficacy is adequate and includes large numbers of patients with appropriate follow‑up periods. Therefore, this procedure may be used provided that normal arrangements are in place for clinical governance, consent and audit.
1.2 As part of the consent process, patients should be informed that there is a range of treatment options available to them and also that further procedures may be needed.
This replaces previous guidance on percutaneous disc decompression using coblation for lower back pain (NICE interventional procedure guidance 173).